News
FerriScan Funding Signals End to Liver Biopsy for Scottish Haemoglobinopathy Patients
The Scottish Paediatric and Adult Haemoglobinopathies Network has secured central funding from the Scottish National Services Directorate for adult patients to access FerriScan R2-MRI (the gold standard measurement of Liver
Resonance Health Partners with CSIRO
We are delighted to announce a new collaboration with one of Australia’s leading research organisations; the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to apply their expertise in our product
Advances for Resonance Health in Measurement of Liver Fibrosis
Excitement is building at Resonance Health regarding promising results from a prototype liver fibrosis measurement. The prototype has been demonstrated to distinguish between low and high fibrosis scores in a
US study addressing fatty liver disease in children using HepaFat-Scan® technology
We are pleased to announce a collaboration with a prestigious children’s hospital in the USA (Children’s Healthcare of Atlanta) who will perform a validation study of HepaFat-Scan® – our non-invasive
Prof. Tim St Pierre Presenting at Licnet Conference in Italy
Resonance Health is proudly attending the Licnet (liver Iron Cutino Network) conference – being held on 8th May 2015 in Palermo, Italy: LIVER DISEASE IN 2015: FROM IRON OVERLOADING TO
Resonance Health Exhibiting at EASL
Resonance Health is proud to be exhibiting at The 50th International Liver Congress.